(Re)defining biopharmaceutical-Reference-Cited by-同舟云学术

(Re)defining biopharmaceutical

Published:2008-07 Issue:7 Volume:26 Page:743-751
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Rader Ronald A

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt0708-743.pdf

Reference30 articles.

1. Rader, R.A. Biopharmaceutical Products in the US and European Markets, 6th ed., 2 vols., (BioPlan Associates, Rockville, MD, 2007). < http://www.biopharma.com/ >

2. Rader, R.A. BioExecutive Intl., March, 60–65 (2005). < http://www.biopharma.com/BioExec_pt1.pdf >

3. Rader, R.A. BioExecutive Intl., May, 42–49 (2005). < http://www.biopharma.com/BioExec_pt2.pdf >

4. Walsh, G. & Jefferis, R. Nat. Biotechnol. 24, 1241–1252 (2006).

5. Akers, M.J. BioProcess Intl. 4, 36–43 (2006).

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histidine-based ionizable cationic surfactants: novel biodegradable agents for hydrophilic macromolecular drug delivery;Drug Delivery and Translational Research;2024-01-30

2. Inducible transgene expression in CHO cells using an artificial transcriptional activator with estrogen‐binding domain;Biotechnology Journal;2023-12-31

3. Transforming Drug Design: Innovations in Computer-Aided Discovery for Biosimilar Agents;BioMedInformatics;2023-12-08

4. Enzyme Engineering Strategies for the Bioenhancement of l-Asparaginase Used as a Biopharmaceutical;BioDrugs;2023-09-12

5. Enhanced Stability Differentiation of Therapeutic Polyclonal Antibodies with All Ion Unfolding-Ion Mobility-Mass Spectrometry;Journal of the American Society for Mass Spectrometry;2023-09-08